At Direvo, we focus on the emerging biomass conversion industry. We identify bottlenecks and weaknesses in current industrial processes in this sector. We develop biology-based solutions and implement those for our partners and customers, which include industrial companies both large and small.
Direvo deploys this groundbreaking platform on the huge opportunity currently being presented by the clean energy, clean chemistry and biomass conversion industries. Direvo’s sister company Direvo Biotech was acquired by Bayer HealthCare in 2008 for $300 million.
Direvo has recently demonstrated a strong proof-of-concept for its enzyme engineering activities in creating a temperature-stable, pH-stable mannanase for animal feed and technical applications.
Direvo is based in Cologne, Germany.
